Chest:慢性阻塞性肺病患者肺康复训练的长期益处

2020-10-23 MedSci原创 MedSci原创

在2年的时间内,有效的8周PR计划可以持续改善COPD患者焦虑和生活质量。8周时呼吸困难、抑郁和应激症状的短期改善在2年时仍能维持。

短期内,肺康复训练(PR)可提高慢性阻塞性肺疾病(COPD)患者的运动能力。近日,呼吸领域权威杂志chest上发表了一篇研究文章,研究人员旨在COPD的患者中探索八周的PR对两年内呼吸困难、焦虑、抑郁和生活质量的长期益处。

165名COPD患者完成了为期八周,基于社区的全面PR计划,包括每周两次,每次两小时的课程。每次PR包括有氧运动和教育计划。鼓励患者在家中每天进行长达30分钟的步行锻炼。研究人员在基线、8周和2年时评估了多种结局指标,包括:改良医学研究委员会(mMRC)问卷测量的呼吸困难、圣乔治呼吸问卷(SGRQ)评估的生活质量以及焦虑量表测量的焦虑呼吸疾病(AIR)和抑郁抑郁焦虑量表(DASS)。此外,研究人员在基线和第8周时使用增量穿梭步行测试(ISWT)测量了运动能力。

受试者平均年龄(SD)为72(8.6)岁;55%是男性。在第8周时,mMRC、SGRQ、ISST、DASS和AIR的改善均具有统计学意义(p<0.001)。在2年的随访期间,在第8周观察到的焦虑症状、症状和总SGRQ得分的变化仍然持续。在多变量分析中,最初的呼吸困难、抑郁、焦虑和运动能力降低可预测2年后生活质量的改善(所有p<0.001)。

在2年的时间内,有效的8周PR计划可以持续改善COPD患者焦虑和生活质量。8周时呼吸困难、抑郁和应激症状的短期改善在2年时仍能维持。

原始出处:

A.M. Yohannes.et al.Long-term benefits of pulmonary rehabilitation in COPD patients: a 2-year follow-up study.chest.2020.https://journal.chestnet.org/article/S0012-3692(20)34927-8/fulltext

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1196408, encodeId=fa2f11964080b, content=很好的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68244995880, createdName=bai_yinge, createdTime=Wed Feb 23 13:34:53 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071714, encodeId=e6e710e171422, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28385710431, createdName=ms8000000632343448, createdTime=Fri Nov 19 11:05:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011841, encodeId=3cea1011841f0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/344b3fd553054361b26a2f7ac5cb0bca/d13b78dd35a846319317aea008c61f2a.jpg, createdBy=b2965586218, createdName=小珊子, createdTime=Thu Aug 26 22:07:22 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671958, encodeId=942716e1958cf, content=<a href='/topic/show?id=58378220131' target=_blank style='color:#2F92EE;'>#肺病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82201, encryptionId=58378220131, topicName=肺病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f0826868454, createdName=amy0559, createdTime=Wed Jul 21 23:20:56 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1929660, encodeId=b1bd19296609f, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Tue Nov 17 13:20:56 CST 2020, time=2020-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006308, encodeId=a334200630817, content=<a href='/topic/show?id=ebc349451d9' target=_blank style='color:#2F92EE;'>#康复训练#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49451, encryptionId=ebc349451d9, topicName=康复训练)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/OKNjeqMuGQiclFVAJtO8Yvicr3uMFOHysUY3EYJses2g3YQKBAT7FzaJwAfeVrbPEPnsiaBAicMAJX7icLdcxzMj0kA/132, createdBy=038e2500100, createdName=ms7517674339485982, createdTime=Fri Aug 13 20:20:56 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696955, encodeId=956e1696955b9, content=<a href='/topic/show?id=d2e99e651e4' target=_blank style='color:#2F92EE;'>#阻塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97651, encryptionId=d2e99e651e4, topicName=阻塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a23129903429, createdName=tomyang96, createdTime=Mon Aug 09 05:20:56 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2058965, encodeId=2dad20589659b, content=<a href='/topic/show?id=9c4f821156f' target=_blank style='color:#2F92EE;'>#肺康复#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82115, encryptionId=9c4f821156f, topicName=肺康复)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e43278, createdName=yangjxjc, createdTime=Sat Jan 30 10:20:56 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051616, encodeId=c5562051616ad, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Fri Nov 13 04:20:56 CST 2020, time=2020-11-13, status=1, ipAttribution=)]
    2022-02-23 bai_yinge

    很好的文章

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1196408, encodeId=fa2f11964080b, content=很好的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68244995880, createdName=bai_yinge, createdTime=Wed Feb 23 13:34:53 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071714, encodeId=e6e710e171422, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28385710431, createdName=ms8000000632343448, createdTime=Fri Nov 19 11:05:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011841, encodeId=3cea1011841f0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/344b3fd553054361b26a2f7ac5cb0bca/d13b78dd35a846319317aea008c61f2a.jpg, createdBy=b2965586218, createdName=小珊子, createdTime=Thu Aug 26 22:07:22 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671958, encodeId=942716e1958cf, content=<a href='/topic/show?id=58378220131' target=_blank style='color:#2F92EE;'>#肺病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82201, encryptionId=58378220131, topicName=肺病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f0826868454, createdName=amy0559, createdTime=Wed Jul 21 23:20:56 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1929660, encodeId=b1bd19296609f, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Tue Nov 17 13:20:56 CST 2020, time=2020-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006308, encodeId=a334200630817, content=<a href='/topic/show?id=ebc349451d9' target=_blank style='color:#2F92EE;'>#康复训练#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49451, encryptionId=ebc349451d9, topicName=康复训练)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/OKNjeqMuGQiclFVAJtO8Yvicr3uMFOHysUY3EYJses2g3YQKBAT7FzaJwAfeVrbPEPnsiaBAicMAJX7icLdcxzMj0kA/132, createdBy=038e2500100, createdName=ms7517674339485982, createdTime=Fri Aug 13 20:20:56 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696955, encodeId=956e1696955b9, content=<a href='/topic/show?id=d2e99e651e4' target=_blank style='color:#2F92EE;'>#阻塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97651, encryptionId=d2e99e651e4, topicName=阻塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a23129903429, createdName=tomyang96, createdTime=Mon Aug 09 05:20:56 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2058965, encodeId=2dad20589659b, content=<a href='/topic/show?id=9c4f821156f' target=_blank style='color:#2F92EE;'>#肺康复#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82115, encryptionId=9c4f821156f, topicName=肺康复)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e43278, createdName=yangjxjc, createdTime=Sat Jan 30 10:20:56 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051616, encodeId=c5562051616ad, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Fri Nov 13 04:20:56 CST 2020, time=2020-11-13, status=1, ipAttribution=)]
    2021-11-19 ms8000000632343448

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1196408, encodeId=fa2f11964080b, content=很好的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68244995880, createdName=bai_yinge, createdTime=Wed Feb 23 13:34:53 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071714, encodeId=e6e710e171422, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28385710431, createdName=ms8000000632343448, createdTime=Fri Nov 19 11:05:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011841, encodeId=3cea1011841f0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/344b3fd553054361b26a2f7ac5cb0bca/d13b78dd35a846319317aea008c61f2a.jpg, createdBy=b2965586218, createdName=小珊子, createdTime=Thu Aug 26 22:07:22 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671958, encodeId=942716e1958cf, content=<a href='/topic/show?id=58378220131' target=_blank style='color:#2F92EE;'>#肺病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82201, encryptionId=58378220131, topicName=肺病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f0826868454, createdName=amy0559, createdTime=Wed Jul 21 23:20:56 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1929660, encodeId=b1bd19296609f, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Tue Nov 17 13:20:56 CST 2020, time=2020-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006308, encodeId=a334200630817, content=<a href='/topic/show?id=ebc349451d9' target=_blank style='color:#2F92EE;'>#康复训练#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49451, encryptionId=ebc349451d9, topicName=康复训练)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/OKNjeqMuGQiclFVAJtO8Yvicr3uMFOHysUY3EYJses2g3YQKBAT7FzaJwAfeVrbPEPnsiaBAicMAJX7icLdcxzMj0kA/132, createdBy=038e2500100, createdName=ms7517674339485982, createdTime=Fri Aug 13 20:20:56 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696955, encodeId=956e1696955b9, content=<a href='/topic/show?id=d2e99e651e4' target=_blank style='color:#2F92EE;'>#阻塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97651, encryptionId=d2e99e651e4, topicName=阻塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a23129903429, createdName=tomyang96, createdTime=Mon Aug 09 05:20:56 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2058965, encodeId=2dad20589659b, content=<a href='/topic/show?id=9c4f821156f' target=_blank style='color:#2F92EE;'>#肺康复#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82115, encryptionId=9c4f821156f, topicName=肺康复)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e43278, createdName=yangjxjc, createdTime=Sat Jan 30 10:20:56 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051616, encodeId=c5562051616ad, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Fri Nov 13 04:20:56 CST 2020, time=2020-11-13, status=1, ipAttribution=)]
    2021-08-26 小珊子

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1196408, encodeId=fa2f11964080b, content=很好的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68244995880, createdName=bai_yinge, createdTime=Wed Feb 23 13:34:53 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071714, encodeId=e6e710e171422, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28385710431, createdName=ms8000000632343448, createdTime=Fri Nov 19 11:05:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011841, encodeId=3cea1011841f0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/344b3fd553054361b26a2f7ac5cb0bca/d13b78dd35a846319317aea008c61f2a.jpg, createdBy=b2965586218, createdName=小珊子, createdTime=Thu Aug 26 22:07:22 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671958, encodeId=942716e1958cf, content=<a href='/topic/show?id=58378220131' target=_blank style='color:#2F92EE;'>#肺病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82201, encryptionId=58378220131, topicName=肺病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f0826868454, createdName=amy0559, createdTime=Wed Jul 21 23:20:56 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1929660, encodeId=b1bd19296609f, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Tue Nov 17 13:20:56 CST 2020, time=2020-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006308, encodeId=a334200630817, content=<a href='/topic/show?id=ebc349451d9' target=_blank style='color:#2F92EE;'>#康复训练#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49451, encryptionId=ebc349451d9, topicName=康复训练)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/OKNjeqMuGQiclFVAJtO8Yvicr3uMFOHysUY3EYJses2g3YQKBAT7FzaJwAfeVrbPEPnsiaBAicMAJX7icLdcxzMj0kA/132, createdBy=038e2500100, createdName=ms7517674339485982, createdTime=Fri Aug 13 20:20:56 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696955, encodeId=956e1696955b9, content=<a href='/topic/show?id=d2e99e651e4' target=_blank style='color:#2F92EE;'>#阻塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97651, encryptionId=d2e99e651e4, topicName=阻塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a23129903429, createdName=tomyang96, createdTime=Mon Aug 09 05:20:56 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2058965, encodeId=2dad20589659b, content=<a href='/topic/show?id=9c4f821156f' target=_blank style='color:#2F92EE;'>#肺康复#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82115, encryptionId=9c4f821156f, topicName=肺康复)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e43278, createdName=yangjxjc, createdTime=Sat Jan 30 10:20:56 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051616, encodeId=c5562051616ad, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Fri Nov 13 04:20:56 CST 2020, time=2020-11-13, status=1, ipAttribution=)]
    2021-07-21 amy0559
  5. [GetPortalCommentsPageByObjectIdResponse(id=1196408, encodeId=fa2f11964080b, content=很好的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68244995880, createdName=bai_yinge, createdTime=Wed Feb 23 13:34:53 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071714, encodeId=e6e710e171422, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28385710431, createdName=ms8000000632343448, createdTime=Fri Nov 19 11:05:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011841, encodeId=3cea1011841f0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/344b3fd553054361b26a2f7ac5cb0bca/d13b78dd35a846319317aea008c61f2a.jpg, createdBy=b2965586218, createdName=小珊子, createdTime=Thu Aug 26 22:07:22 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671958, encodeId=942716e1958cf, content=<a href='/topic/show?id=58378220131' target=_blank style='color:#2F92EE;'>#肺病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82201, encryptionId=58378220131, topicName=肺病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f0826868454, createdName=amy0559, createdTime=Wed Jul 21 23:20:56 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1929660, encodeId=b1bd19296609f, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Tue Nov 17 13:20:56 CST 2020, time=2020-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006308, encodeId=a334200630817, content=<a href='/topic/show?id=ebc349451d9' target=_blank style='color:#2F92EE;'>#康复训练#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49451, encryptionId=ebc349451d9, topicName=康复训练)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/OKNjeqMuGQiclFVAJtO8Yvicr3uMFOHysUY3EYJses2g3YQKBAT7FzaJwAfeVrbPEPnsiaBAicMAJX7icLdcxzMj0kA/132, createdBy=038e2500100, createdName=ms7517674339485982, createdTime=Fri Aug 13 20:20:56 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696955, encodeId=956e1696955b9, content=<a href='/topic/show?id=d2e99e651e4' target=_blank style='color:#2F92EE;'>#阻塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97651, encryptionId=d2e99e651e4, topicName=阻塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a23129903429, createdName=tomyang96, createdTime=Mon Aug 09 05:20:56 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2058965, encodeId=2dad20589659b, content=<a href='/topic/show?id=9c4f821156f' target=_blank style='color:#2F92EE;'>#肺康复#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82115, encryptionId=9c4f821156f, topicName=肺康复)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e43278, createdName=yangjxjc, createdTime=Sat Jan 30 10:20:56 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051616, encodeId=c5562051616ad, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Fri Nov 13 04:20:56 CST 2020, time=2020-11-13, status=1, ipAttribution=)]
    2020-11-17 Smile2680
  6. [GetPortalCommentsPageByObjectIdResponse(id=1196408, encodeId=fa2f11964080b, content=很好的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68244995880, createdName=bai_yinge, createdTime=Wed Feb 23 13:34:53 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071714, encodeId=e6e710e171422, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28385710431, createdName=ms8000000632343448, createdTime=Fri Nov 19 11:05:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011841, encodeId=3cea1011841f0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/344b3fd553054361b26a2f7ac5cb0bca/d13b78dd35a846319317aea008c61f2a.jpg, createdBy=b2965586218, createdName=小珊子, createdTime=Thu Aug 26 22:07:22 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671958, encodeId=942716e1958cf, content=<a href='/topic/show?id=58378220131' target=_blank style='color:#2F92EE;'>#肺病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82201, encryptionId=58378220131, topicName=肺病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f0826868454, createdName=amy0559, createdTime=Wed Jul 21 23:20:56 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1929660, encodeId=b1bd19296609f, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Tue Nov 17 13:20:56 CST 2020, time=2020-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006308, encodeId=a334200630817, content=<a href='/topic/show?id=ebc349451d9' target=_blank style='color:#2F92EE;'>#康复训练#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49451, encryptionId=ebc349451d9, topicName=康复训练)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/OKNjeqMuGQiclFVAJtO8Yvicr3uMFOHysUY3EYJses2g3YQKBAT7FzaJwAfeVrbPEPnsiaBAicMAJX7icLdcxzMj0kA/132, createdBy=038e2500100, createdName=ms7517674339485982, createdTime=Fri Aug 13 20:20:56 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696955, encodeId=956e1696955b9, content=<a href='/topic/show?id=d2e99e651e4' target=_blank style='color:#2F92EE;'>#阻塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97651, encryptionId=d2e99e651e4, topicName=阻塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a23129903429, createdName=tomyang96, createdTime=Mon Aug 09 05:20:56 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2058965, encodeId=2dad20589659b, content=<a href='/topic/show?id=9c4f821156f' target=_blank style='color:#2F92EE;'>#肺康复#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82115, encryptionId=9c4f821156f, topicName=肺康复)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e43278, createdName=yangjxjc, createdTime=Sat Jan 30 10:20:56 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051616, encodeId=c5562051616ad, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Fri Nov 13 04:20:56 CST 2020, time=2020-11-13, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1196408, encodeId=fa2f11964080b, content=很好的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68244995880, createdName=bai_yinge, createdTime=Wed Feb 23 13:34:53 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071714, encodeId=e6e710e171422, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28385710431, createdName=ms8000000632343448, createdTime=Fri Nov 19 11:05:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011841, encodeId=3cea1011841f0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/344b3fd553054361b26a2f7ac5cb0bca/d13b78dd35a846319317aea008c61f2a.jpg, createdBy=b2965586218, createdName=小珊子, createdTime=Thu Aug 26 22:07:22 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671958, encodeId=942716e1958cf, content=<a href='/topic/show?id=58378220131' target=_blank style='color:#2F92EE;'>#肺病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82201, encryptionId=58378220131, topicName=肺病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f0826868454, createdName=amy0559, createdTime=Wed Jul 21 23:20:56 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1929660, encodeId=b1bd19296609f, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Tue Nov 17 13:20:56 CST 2020, time=2020-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006308, encodeId=a334200630817, content=<a href='/topic/show?id=ebc349451d9' target=_blank style='color:#2F92EE;'>#康复训练#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49451, encryptionId=ebc349451d9, topicName=康复训练)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/OKNjeqMuGQiclFVAJtO8Yvicr3uMFOHysUY3EYJses2g3YQKBAT7FzaJwAfeVrbPEPnsiaBAicMAJX7icLdcxzMj0kA/132, createdBy=038e2500100, createdName=ms7517674339485982, createdTime=Fri Aug 13 20:20:56 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696955, encodeId=956e1696955b9, content=<a href='/topic/show?id=d2e99e651e4' target=_blank style='color:#2F92EE;'>#阻塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97651, encryptionId=d2e99e651e4, topicName=阻塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a23129903429, createdName=tomyang96, createdTime=Mon Aug 09 05:20:56 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2058965, encodeId=2dad20589659b, content=<a href='/topic/show?id=9c4f821156f' target=_blank style='color:#2F92EE;'>#肺康复#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82115, encryptionId=9c4f821156f, topicName=肺康复)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e43278, createdName=yangjxjc, createdTime=Sat Jan 30 10:20:56 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051616, encodeId=c5562051616ad, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Fri Nov 13 04:20:56 CST 2020, time=2020-11-13, status=1, ipAttribution=)]
    2021-08-09 tomyang96
  8. [GetPortalCommentsPageByObjectIdResponse(id=1196408, encodeId=fa2f11964080b, content=很好的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68244995880, createdName=bai_yinge, createdTime=Wed Feb 23 13:34:53 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071714, encodeId=e6e710e171422, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28385710431, createdName=ms8000000632343448, createdTime=Fri Nov 19 11:05:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011841, encodeId=3cea1011841f0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/344b3fd553054361b26a2f7ac5cb0bca/d13b78dd35a846319317aea008c61f2a.jpg, createdBy=b2965586218, createdName=小珊子, createdTime=Thu Aug 26 22:07:22 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671958, encodeId=942716e1958cf, content=<a href='/topic/show?id=58378220131' target=_blank style='color:#2F92EE;'>#肺病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82201, encryptionId=58378220131, topicName=肺病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f0826868454, createdName=amy0559, createdTime=Wed Jul 21 23:20:56 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1929660, encodeId=b1bd19296609f, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Tue Nov 17 13:20:56 CST 2020, time=2020-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006308, encodeId=a334200630817, content=<a href='/topic/show?id=ebc349451d9' target=_blank style='color:#2F92EE;'>#康复训练#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49451, encryptionId=ebc349451d9, topicName=康复训练)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/OKNjeqMuGQiclFVAJtO8Yvicr3uMFOHysUY3EYJses2g3YQKBAT7FzaJwAfeVrbPEPnsiaBAicMAJX7icLdcxzMj0kA/132, createdBy=038e2500100, createdName=ms7517674339485982, createdTime=Fri Aug 13 20:20:56 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696955, encodeId=956e1696955b9, content=<a href='/topic/show?id=d2e99e651e4' target=_blank style='color:#2F92EE;'>#阻塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97651, encryptionId=d2e99e651e4, topicName=阻塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a23129903429, createdName=tomyang96, createdTime=Mon Aug 09 05:20:56 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2058965, encodeId=2dad20589659b, content=<a href='/topic/show?id=9c4f821156f' target=_blank style='color:#2F92EE;'>#肺康复#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82115, encryptionId=9c4f821156f, topicName=肺康复)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e43278, createdName=yangjxjc, createdTime=Sat Jan 30 10:20:56 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051616, encodeId=c5562051616ad, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Fri Nov 13 04:20:56 CST 2020, time=2020-11-13, status=1, ipAttribution=)]
  9. [GetPortalCommentsPageByObjectIdResponse(id=1196408, encodeId=fa2f11964080b, content=很好的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68244995880, createdName=bai_yinge, createdTime=Wed Feb 23 13:34:53 CST 2022, time=2022-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1071714, encodeId=e6e710e171422, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28385710431, createdName=ms8000000632343448, createdTime=Fri Nov 19 11:05:07 CST 2021, time=2021-11-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011841, encodeId=3cea1011841f0, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/344b3fd553054361b26a2f7ac5cb0bca/d13b78dd35a846319317aea008c61f2a.jpg, createdBy=b2965586218, createdName=小珊子, createdTime=Thu Aug 26 22:07:22 CST 2021, time=2021-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671958, encodeId=942716e1958cf, content=<a href='/topic/show?id=58378220131' target=_blank style='color:#2F92EE;'>#肺病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82201, encryptionId=58378220131, topicName=肺病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2f0826868454, createdName=amy0559, createdTime=Wed Jul 21 23:20:56 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1929660, encodeId=b1bd19296609f, content=<a href='/topic/show?id=9e604625ab' target=_blank style='color:#2F92EE;'>#Chest#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4625, encryptionId=9e604625ab, topicName=Chest)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c48a270, createdName=Smile2680, createdTime=Tue Nov 17 13:20:56 CST 2020, time=2020-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006308, encodeId=a334200630817, content=<a href='/topic/show?id=ebc349451d9' target=_blank style='color:#2F92EE;'>#康复训练#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49451, encryptionId=ebc349451d9, topicName=康复训练)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/OKNjeqMuGQiclFVAJtO8Yvicr3uMFOHysUY3EYJses2g3YQKBAT7FzaJwAfeVrbPEPnsiaBAicMAJX7icLdcxzMj0kA/132, createdBy=038e2500100, createdName=ms7517674339485982, createdTime=Fri Aug 13 20:20:56 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1696955, encodeId=956e1696955b9, content=<a href='/topic/show?id=d2e99e651e4' target=_blank style='color:#2F92EE;'>#阻塞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97651, encryptionId=d2e99e651e4, topicName=阻塞)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a23129903429, createdName=tomyang96, createdTime=Mon Aug 09 05:20:56 CST 2021, time=2021-08-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2058965, encodeId=2dad20589659b, content=<a href='/topic/show?id=9c4f821156f' target=_blank style='color:#2F92EE;'>#肺康复#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82115, encryptionId=9c4f821156f, topicName=肺康复)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e43278, createdName=yangjxjc, createdTime=Sat Jan 30 10:20:56 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2051616, encodeId=c5562051616ad, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Fri Nov 13 04:20:56 CST 2020, time=2020-11-13, status=1, ipAttribution=)]

相关资讯

Verona Pharma公布ensifentrine作为慢性阻塞性肺病(COPD)维持治疗的II期临床结果

Verona Pharma公司已发布ensifentrine作为慢性阻塞性肺病(COPD)维持治疗的II期临床试验结果。结果表明,该研究达到了主要终点,ensifentrine在所有剂量下均能在临床和统计学上显着改善肺功能。同样达到了临床相关的次要终点,包括COPD症状的显着进行性改善。

Eur Arch Otorhinolaryngol:非传染性鼻炎与早发COPD具有更强的相关性

慢性阻塞性肺病(COPD)与一些并发症相关,非传染性鼻炎(NIR)已经成为了一种新的并发症。最近,有研究人员确定了之前一个多中心群体研究报道的NIR与COPD之间的相关性,并调查了上述相关性随着时间变化的情况,即比较了早发与晚发COPD与NIR的相关性情况。他们的研究属于欧盟呼吸健康调查(ECRHS)的一部分。群体为来自欧洲25个中心的随机成年人群体和一个来自于澳大利亚的群体,并进行呼吸量测定和呼

JAMA:极早进行肺康复治疗可降低慢性阻塞性肺病恶化患者死亡风险

研究认为,对于慢性阻塞性肺病恶化患者,在出院后3个月内开始肺康复与1年死亡率的降低显著相关

英国NICE发布了新型冠状病毒COVID-19管理指南:针对囊性纤维化、慢性阻塞性肺病和需要使用会影响免疫系统药物的皮肤病患者

COVID-19快速指南:囊性纤维化患者、慢性阻塞性肺部疾病患者、需要使用会影响免疫系统药物的皮肤病患者

Chest:慢性阻塞性肺病患者慢性咳嗽的临床意义

由此可见,就较多的呼吸道症状和医疗保健使用情况,较低的肺功能和较高炎症水平来看,COPD患者合并慢性咳嗽会导致更严重的病情。

2019 SATS立场声明:慢性阻塞性肺疾病的管理(更新版)

简要介绍:2019年11月,南非胸科学会(SATS)更新发布了慢性阻塞性肺疾病的管理声明,慢性阻塞性肺疾病(COPD)是导致,发展中国家致残和死亡的重要原因。本文是南非胸科学会(SATS)对2012年版慢性阻塞性肺疾病的管理指南的更新。